Scarica l'app Stockscreener
137.00
6.81%
-10.01
Pre-mercato:
137.00
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RGEN Giù?
Forum
Previsione
Repligen Corp Borsa (RGEN) Ultime notizie
A Look at Repligen Corp (RGEN) After 6.8% Decline -- GF Value $1 - GuruFocus
Insider Sell: Jason Garland Sells Shares of Repligen Corp (RGEN) - GuruFocus
Biolife Is Said to Have Drawn Takeover Interest From Repligen - Bloomberg.com
Repligen (RGEN) CFO completes 733-share Rule 10b5-1 stock sale - Stock Titan
A Look at Repligen Corp (RGEN) After 4.9% Gain -- GF Value $175. - GuruFocus
Stock Market Today, June 25: Bio-Techne Surges After Merck KGaA Announces $73-Per-Share Cash Acquisition Offer - The Motley Fool
Form 144 REPLIGEN CORP For: 25 June By Investing.com - Investing.com Australia
[144] REPLIGEN CORP SEC Filing - Stock Titan
Repligen jumps as investors revisit strong Q1 results and bioprocessing recovery outlook - Quiver Quantitative
Repligen Corporation (RGEN) Dropped Following the Earnings Release - Insider Monkey
Repligen Corp (RGEN) Shares Fall 4.1% -- What GF Score of 83 Tel - GuruFocus
Repligen Corp (RGEN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Repligen StockLong-term strategy and bioprocessing niche - AD HOC NEWS
Repligen Corporation (RGEN) Slid on Softened Enthusiasm for Life Sciences Tools - Insider Monkey
RGEN Technical Analysis & Stock Price Forecast - Intellectia AI
Repligen Corp (RGEN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Repligen Corp (RGEN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Repligen Corp (RGEN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Repligen Corp (RGEN) Valuation: PE, PB & Fair Value Analysis - TradingKey
Repligen Corp (RGEN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Repligen Corp (RGEN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Repligen Corp (RGEN) Institutional Confidence - TradingKey
Repligen Corp (RGEN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
MFS Mid Cap Growth Series's Repligen Corp(RGEN) Holding History - GuruFocus
RBC Capital Resumes Repligen Corp (RGEN) Stock Coverage. Here’s Its View - Insider Monkey
Billionaire Lee Ainslie’s 5 Stocks with Huge Upside Potential - Insider Monkey
Repligen Corp. Hits Day High with 8.45% Surge in Stock Price - Markets Mojo
Multi Cap Equity Fund's Repligen Corp(RGEN) Holding History - GuruFocus
Repligen Corp (RGEN) Shares Surge 3.8% -- What GF Score of 83 Te - GuruFocus
Repligen Corp (RGEN) Shares Surge 4.0% -- What GF Score of 79 Te - GuruFocus
Repligen (RGEN) down 3.2% since last earnings report: Can it rebound? - MSN
Repligen (RGEN) Down 3.2% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
State Street Small-Cap Equity V.I.S. Fund's Repligen Corp(RGEN) Holding History - GuruFocus
Repligen Corp at William Blair Growth Stock Conference Transcript - GuruFocus
RGEN Assumed by Wolfe Research -- Rating Upgraded to Outperform - GuruFocus
Wolfe Research initiates Repligen stock coverage with outperform rating By Investing.com - Investing.com Australia
Wolfe Research initiates Repligen stock coverage with outperform rating - Investing.com
Repligen Has A Cleaner Recovery Angle, But With High Valuation - Seeking Alpha
Repligen Corp stock (US7607591002): RGEN jumps after strong Nasdaq session - AD HOC NEWS
Repligen Corp (RGEN) Stock Up 8.4% and Still Undervalued -- GF S - GuruFocus
RGENRepligen Corp Stock Price and Quote - Finviz
Repligen's $833 Million Guide: Can Analytics And China Power The Next Leg? - Smartkarma
Repligen Jumps 12% This Week as June Investor Update Approaches - Bez Kabli
Repligen (RGEN) Edges Higher Amid Bioprocessing Sector OptimismFibonacci Arc - The Legal Advocate
Hear Repligen's CEO give company overview at June 3 webcast - Stock Titan
Repligen Corporation to Present at William Blair 46th Annual Growth Stock Conference - Yahoo Finance
Repligen Corp stock (US7607591002): ESG progress and growth focus draw fresh attention - AD HOC NEWS
InvestingPro’s Fair Value model predicted Repligen’s 45% decline By Investing.com - Investing.com Canada
Q1 Rundown: Repligen (NASDAQ:RGEN) Vs Other Drug Development Inputs & Services Stocks - Yahoo Finance
Repligen’s 2025 Sustainability Report Highlights Carbon Emission Reductions and ESG Progress - geneonline.com
Repligen Announces Publication of the Company’s 2025 Corporate Sustainability Report - Yahoo Finance
Repligen keeps factories on 100% renewable power, cuts water use 14% - Stock Titan
Repligen Corp (RGEN) Stock Up 4.2% and Still Undervalued -- GF S - GuruFocus
Repligen shares jump 4.1% as investors buy the dip after a sharp selloff; prior guidance update and short-covering may be factors - Quiver Quantitative
0.09%
0.52%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):